These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Efficacy of percutaneous and transcutaneous tibial nerve stimulation in women with idiopathic overactive bladder: A prospective randomised controlled trial. Sonmez R, Yildiz N, Alkan H. Ann Phys Rehabil Med; 2022 Jan; 65(1):101486. PubMed ID: 33429090 [Abstract] [Full Text] [Related]
6. Predictors of successful percutaneous tibial nerve stimulation (PTNS) in the treatment of overactive bladder syndrome. Rostaminia G, Chang C, Pincus JB, Sand PK, Goldberg RP. Int Urogynecol J; 2019 Oct; 30(10):1735-1745. PubMed ID: 30498931 [Abstract] [Full Text] [Related]
7. Factors associated with overactive bladder symptom improvement after 1 year of monthly percutaneous tibial nerve stimulation therapy. Pincus J, Rostaminia G, Chang C, Gafni-Kane A, Goldberg RP. Neurourol Urodyn; 2019 Aug; 38(6):1676-1684. PubMed ID: 31107570 [Abstract] [Full Text] [Related]
10. Transcutaneous posterior tibial nerve stimulation in pediatric overactive bladder: A preliminary report. Patidar N, Mittal V, Kumar M, Sureka SK, Arora S, Ansari MS. J Pediatr Urol; 2015 Dec; 11(6):351.e1-6. PubMed ID: 26279104 [Abstract] [Full Text] [Related]
11. Persistence in Percutaneous Tibial Nerve Stimulation Treatment for Overactive Bladder Syndrome is Best Predicted by Patient Global Impression of Improvement Rather Than Symptom-Specific Improvement. Brandon C, Oh C, Brucker BM, Rosenblum N, Ferrante KL, Smilen SW, Nitti VW, Pape DM. Urology; 2021 Feb; 148():93-99. PubMed ID: 33358753 [Abstract] [Full Text] [Related]
12. Percutaneous Tibial Nerve Stimulation Improves Female Sexual Function in Women With Overactive Bladder Syndrome. Musco S, Serati M, Lombardi G, Lumi E, Parisi AI, Del Popolo G, Finazzi Agrò E. J Sex Med; 2016 Feb; 13(2):238-42. PubMed ID: 26803455 [Abstract] [Full Text] [Related]
19. Long-term real-life adherence of percutaneous tibial nerve stimulation in over 400 patients. Te Dorsthorst MJ, Heesakkers JPFA, van Balken MR. Neurourol Urodyn; 2020 Feb; 39(2):702-706. PubMed ID: 31845404 [Abstract] [Full Text] [Related]
20. Shifts in patient preference of third-line overactive bladder therapy after introduction of the implantable tibial nerve stimulator. Kapur A, Aalami Harandi A, Hartman-Kenzler J, Kim J. Neurourol Urodyn; 2024 Apr; 43(4):959-966. PubMed ID: 38390786 [Abstract] [Full Text] [Related] Page: [Next] [New Search]